Skip to content
Xenon Pharmaceuticals Inc icon

Xenon Pharmaceuticals Inc

XENEStocksPharmaceuticals MajorCanadaNasdaqUSD

Price

$38.02

Today

+4.1%

YTD

-14.9%

About

Xenon Pharmaceuticals Inc is a progressive clinical-stage biopharmaceutical corporation focused on developing innovative therapies to enhance the lives of patients with neurological disorders. The company works in designing paths toward vitally needed drugs, employing its innovative Extreme Genetics discovery platform for ultimately solving the mysteries of disease. Operating within the biopharmaceutical industry, Xenon offers an array of incredibly specialised services, including the research, development, and marketing of pharmaceutical products. Keep up to date on the latest share price changes by adding XENE stock to your eToro watchlist.

Price chart
Closing price history for XENE (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.

Open positions

0

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)-14.65
P/S (TTM)0.00
P/B (TTM)4.98
Market cap$6.66B
Cap tierMid-cap
Industry avg P/E-43.36

Profitability

Gross margin66.09%
EBIT margin0.00%
Net margin-867.29%
ROE-37.53%
ROA-35.98%

Earnings & Revenue

Revenue (TTM)$0.00
Revenue growth (1Y)-100.0%
EPS (TTM)-$4.70
Free cash flow$-307.84M
Total debt$7.49M

Dividends & Risk

Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)0.85
Employees370
Next earnings2 Nov '26
Trade history

Closed trades

0

Realized return

+0.0%

No stored closed trades exist for this instrument yet.

Xenon Pharmaceuticals Inc (XENE) | Dirk Kuyken